SEC Filing Summary: Tempur-Pedic International Inc. (Form 8-K)
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Tempur-Pedic International Inc. on June 29, 2011, reporting events occurring on June 28, 2011. The filing details the entry into a material definitive agreement regarding the company's credit facilities.
Key Financial Metrics and Debt Structure
The filing focuses on debt capacity and liquidity rather than operating performance metrics such as revenue or profit, which are not disclosed in this document.
- Total Credit Facility Availability: Increased to $770 million.
- Domestic Revolver Increase: Commitments increased by $130 million.
- Expansion Option: The company retains an option to increase the domestic revolver by an additional $250 million.
- Facility Expiration: Extended to June 2016.
- Interest Margins and Fees: Adjusted to current market conditions. For example, if the Consolidated Leverage Ratio is between 1.0:1.0 and 1.75:1.0, the Applicable Margin for Eurocurrency Loans is 1.75%, and the Commitment Fee on unused commitments is 0.375%.
Material Changes Versus Prior Period
The primary material change is the amendment and restatement of the Credit Agreement originally dated October 18, 2005. Key changes include:
- Expansion of total borrowing capacity.
- Extension of the maturity date by several years.
- Adjustment of pricing terms (margins and fees) to reflect current market conditions.
Outlook, Management Commentary, and Risks
Management indicated that funds borrowed under the amended facility are expected to be used for general corporate purposes. Specifically, the company noted these funds could be utilized to fund share repurchases. The filing does not provide specific forward-looking guidance on revenue or earnings, nor does it detail specific risks beyond the standard terms of the credit agreement.
Key Facts for Investor Verification
- Verify the current Consolidated Leverage Ratio to determine the applicable interest margin and commitment fees.
- Confirm the utilization rate of the new $770 million facility to assess immediate liquidity needs.
- Monitor future announcements regarding the potential exercise of the $250 million accordion option.
- Review subsequent filings for details on any share repurchase activities funded by this facility.